Between Dec 18 , 2006 , and July 22 , 2013 , 3425 eligible patients were enrolled into the trial , of whom 3420 were randomly assigned to receive denosumab 60 mg ( n = 1711 ) or placebo ( n = 1709 ) subcutaneously every 6 months .